Ketamine Recruiting Phase 3 Trials for refractory seizure disorders Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02431663Ketamine in Refractory Convulsive Status Epilepticus